Epidemiology

You have full text access to this OnlineOpen article

Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies

  1. Jung Eun Lee1,†,*,
  2. David J. Hunter1,2,3,
  3. Donna Spiegelman3,4,
  4. Hans-Olov Adami3,5,
  5. Leslie Bernstein6,
  6. Piet A. van den Brandt7,
  7. Julie E. Buring3,8,
  8. Eunyoung Cho1,
  9. Dallas English9,
  10. Aaron R. Folsom10,
  11. Jo L. Freudenheim11,
  12. Graham G. Gile9,
  13. Edward Giovannucci1,2,3,
  14. Pamela L. Horn-Ross12,
  15. Michael Leitzmann13,
  16. James R. Marshall14,
  17. Satu Männistö15,
  18. Marjorie L. McCullough16,
  19. Anthony B. Miller17,
  20. Alexander S. Parker18,
  21. Pirjo Pietinen15,
  22. Carmen Rodriguez16,
  23. Thomas E. Rohan19,
  24. Arthur Schatzkin13,
  25. Leo J. Schouten7,
  26. Walter C. Willett1,2,3,
  27. Alicja Wolk20,
  28. Shumin M. Zhang3,8,
  29. Stephanie A. Smith-Warner2,3

Article first published online: 21 JUN 2007

DOI: 10.1002/ijc.22909

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 10, pages 2246–2253, 15 November 2007

Additional Information

How to Cite

Lee, J. E., Hunter, D. J., Spiegelman, D., Adami, H.-O., Bernstein, L., van den Brandt, P. A., Buring, J. E., Cho, E., English, D., Folsom, A. R., Freudenheim, J. L., Gile, G. G., Giovannucci, E., Horn-Ross, P. L., Leitzmann, M., Marshall, J. R., Männistö, S., McCullough, M. L., Miller, A. B., Parker, A. S., Pietinen, P., Rodriguez, C., Rohan, T. E., Schatzkin, A., Schouten, L. J., Willett, W. C., Wolk, A., Zhang, S. M. and Smith-Warner, S. A. (2007), Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int. J. Cancer, 121: 2246–2253. doi: 10.1002/ijc.22909

Author Information

  1. 1

    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  2. 2

    Department of Nutrition, Harvard School of Public Health, Boston, MA

  3. 3

    Department of Epidemiology, Harvard School of Public Health, Boston, MA

  4. 4

    Department of Biostatistics, Harvard School of Public Health, Boston, MA

  5. 5

    Department of Medical Epidemiology and Biostatistics, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  6. 6

    Department of Preventive Medicine and USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA

  7. 7

    Department of Epidemiology, NUTRIM, Maastricht University, Maastricht, The Netherlands

  8. 8

    Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  9. 9

    Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia

  10. 10

    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN

  11. 11

    Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo, NY

  12. 12

    Northern California Cancer Center, Fremont, CA

  13. 13

    Division of Cancer Epidemiology and Genetics, Department of Health and Health Services, National Cancer Institute, National Institute of Health, Bethesda, MD

  14. 14

    Roswell Park Cancer Institute, Buffalo, NY

  15. 15

    Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland

  16. 16

    Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA

  17. 17

    Department of Public Health Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

  18. 18

    Department of Urology, Mayo Clinic College of Medicine, Jacksonville, FL

  19. 19

    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY

  20. 20

    Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  1. †

    Fax: +1-1-617-525-2008.

*Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 21 JUN 2007
  3. Manuscript Accepted: 3 MAY 2007
  4. Manuscript Received: 15 DEC 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (110K)

References

  • 1
    Mathew A, Devesa SS, Fraumeni JF,Jr, Chow WH. Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 2002; 11: 171–8.
  • 2
    Vander A, Sherman J, Luciano D. Human physiology: The mechanisms of body function, 6th edn. New York: McGraw-Hill, 1994.
  • 3
    Kehrer JP, Smith CV. Free radicals in biology: sources, reactivities, and roles in the etiology of human diseases. In: FreiB, ed. Natural antioxidants in human health and disease. San Diego, CA: Academic Press, 1994. 25–62.
  • 4
    Arnlov J, Vessby B, Riserus U. Coffee consumption and insulin sensitivity. JAMA 2004; 291: 1199–201.
  • 5
    Anderson RA, Polansky MM. Tea enhances insulin activity. J Agric Food Chem 2002; 50: 7182–6.
  • 6
    Chow WH, Gridley G, McLaughlin JK, Mandel JS, Wacholder S, Blot WJ, Niwa S, Fraumeni JF,Jr. Protein intake and risk of renal cell cancer. J Natl Cancer Inst 1994; 86: 1131–9.
  • 7
    Goodman MT, Morgenstern H, Wynder EL. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol 1986; 124: 926–41.
  • 8
    Asal NR, Risser DR, Kadamani S, Geyer JR, Lee ET, Cherng N. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity. Cancer Detect Prev 1988; 11: 359–77.
  • 9
    Maclure M, Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology 1990; 1: 430–40.
  • 10
    McCredie M, Ford JM, Stewart JH. Risk factors for cancer of the renal parenchyma. Int J Cancer 1988; 42: 13–6.
    Direct Link:
  • 11
    Talamini R, Baron AE, Barra S, Bidoli E, La Vecchia C, Negri E, Serraino D, Franceschi S. A case-control study of risk factor for renal cell cancer in northern Italy. Cancer Causes Control 1990; 1: 125–31.
  • 12
    Benhamou S, Lenfant MH, Ory-Paoletti C, Flamant R. Risk factors for renal-cell carcinoma in a French case-control study. Int J Cancer 1993; 55: 32–6.
    Direct Link:
  • 13
    Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control 1993; 4: 101–10.
  • 14
    Yuan JM, Gago-Dominguez M, Castelao JE, Hankin JH, Ross RK, Yu MC. Cruciferous vegetables in relation to renal cell carcinoma. Int J Cancer 1998; 77: 211–6.
    Direct Link:
  • 15
    Bianchi GD, Cerhan JR, Parker AS, Putnam SD, See WA, Lynch CF, Cantor KP. Tea consumption and risk of bladder and kidney cancers in a population- based case-control study. Am J Epidemiol 2000; 151: 377–83.
  • 16
    McLaughlin JK, Mandel JS, Blot WJ, Schuman LM, Mehl ES, Fraumeni JF,Jr. A population-based case-control study of renal cell carcinoma. J Natl Cancer Inst 1984; 72: 275–84.
  • 17
    Yu MC, Mack TM, Hanisch R, Cicioni C, Henderson BE. Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma. J Natl Cancer Inst 1986; 77: 351–6.
  • 18
    Wolk A, Gridley G, Niwa S, Lindblad P, McCredie M, Mellemgaard A, Mandel JS, Wahrendorf J, McLaughlin JK, Adami HO. International renal cell cancer study. VII. Role of diet. Int J Cancer 1996; 65: 67–73.
    Direct Link:
  • 19
    Hu J, Mao Y, White K. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control 2003; 14: 705–14.
  • 20
    Mellemgaard A, McLaughlin JK, Overvad K, Olsen JH. Dietary risk factors for renal cell carcinoma in Denmark. Eur J Cancer 1996; 32A: 673–82.
  • 21
    Lindblad P, Wolk A, Bergstrom R, Adami HO. Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 1997; 6: 215–23.
  • 22
    Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomarkers Prev 2006; 15: 1204–11.
  • 23
    Rashidkhani B, Lindblad P, Wolk A. Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women. Int J Cancer 2005; 113: 451–5.
    Direct Link:
  • 24
    Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer 2004; 108: 115–21.
    Direct Link:
  • 25
    Washio M, Mori M, Sakauchi F, Watanabe Y, Ozasa K, Hayashi K, Miki T, Nakao M, Mikami K, Ito Y, Wakai K, Tamakoshi A. Risk factors for kidney cancer in a Japanese population: findings from the JACC Study. J Epidemiol 2005; 15 ( Suppl 2): S203–11.
  • 26
    Lee JE, Hunter DJ, Spiegelman D, Adami HO, Albanes D, Bernstein L, van den Brandt PA, Buring JE, Cho E, Folsom AR, Freudenheim JL, Giovannucci E, et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst, 2007; 99: 801–10.
  • 27
    Smith-Warner SA, Spiegelman D, Ritz J, Albanes D, Beeson WL, Bernstein L, Berrino F, van den Brandt PA, Buring JE, Cho E, Colditz GA, Folsom AR, et al. Methods for pooling results of epidemiologic studies. Am J Epidemiol 2006; 163: 1053–64.
  • 28
    Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986; 73: 1–12.
  • 29
    Higginbotham S, Zhang ZF, Lee IM, Cook NR, Giovannucci E, Buring JE, Liu S. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004; 96: 229–33.
  • 30
    Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002; 156: 69–70.
  • 31
    van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA. Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands cohort study. Int J Cancer 2005; 117: 648–54.
    Direct Link:
  • 32
    Rohan TE, Jain M, Howe GR, Miller AB. Alcohol consumption and risk of breast cancer: a cohort study. Cancer Causes Control 2000; 11: 239–47.
  • 33
    Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, et al. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 2002; 13: 625–35.
  • 34
    Bandera EV, Freudenheim JL, Marshall JR, Zielezny M, Priore RL, Brasure J, Baptiste M, Graham S. Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States). Cancer Causes Control 1997; 8: 828–40.
  • 35
    Mahabir S, Leitzmann MF, Virtanen MJ, Virtamo J, Pietinen P, Albanes D, Taylor PR. Prospective study of alcohol drinking and renal cell cancer risk in a cohort of finnish male smokers. Cancer Epidemiol Biomarkers Prev 2005; 14: 170–5.
  • 36
    Flood A, Caprario L, Chaterjee N, Lacey JV,Jr, Schairer C, Schatzkin A. Folate, methionine, alcohol, and colorectal cancer in a prospective study of women in the United States. Cancer Causes Control 2002; 13: 551–61.
  • 37
    Calle EE, Rodriguez C, Jacobs EJ, Almon ML, Chao A, McCullough ML, Feigelson HS, Thun MJ. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 2002; 94: 500–11.
    Direct Link:
  • 38
    Percy C, Van Holten V, Muir C. International classification of diseases for oncology. World Health Organ 1990.
  • 39
    Puckett CD. The educational annotation of ICD-9-CM; diseases and procedures tabular lists. Reno, Nevada: Channel Publishing, 1986.
  • 40
    Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K. Classification of renal cell carcinoma: workgroup No. 1. Cancer 1997; 80: 987–9.
    Direct Link:
  • 41
    Baglietto L, Severi G, English DR, Hopper JL, Giles GG. Alcohol consumption and prostate cancer risk: results from the Melbourne collaborative cohort study. Int J Cancer 2006; 119: 1501–4.
    Direct Link:
  • 42
    Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790–6.
  • 43
    Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858–67.
  • 44
    Pietinen P, Hartman AM, Haapa E, Räsänen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988; 128: 655–66.
  • 45
    Goldbohm RA, van den Brandt PA, Brants HAM, van't Veer P, Al M, Sturmans F, Hermus RJJ. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994; 48: 253–65.
  • 46
    Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187–220.
  • 47
    Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963–74.
  • 48
    Harville DA. Maximum likelihood approaches to variance component estimation and to related problems. J Am Stat Assoc 1977; 72: 320–40.
  • 49
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–88.
  • 50
    Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101–29.
  • 51
    Smith PL. Splines as a useful and convenient statistical tool. Am Stat 1979; 33: 57–62.
  • 52
    Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551–61.
    Direct Link:
  • 53
    Stram DO. Meta-analysis of published data using a linear mixed-effects model. Biometrics 1996; 52: 536–44.
  • 54
    Pollock BG, Wylie M, Stack JA, Sorisio DA, Thompson DS, Kirshner MA, Folan MM, Condifer KA. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 1999; 39: 936–40.
  • 55
    Balogh A, Klinger G, Henschel L, Borner A, Vollanth R, Kuhnz W. Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination. Eur J Clin Pharmacol 1995; 48: 161–6.
  • 56
    Shennan DH. Letter: renal carcinoma and coffee consumption in 16 countries. Br J Cancer 1973; 28: 473–4.
  • 57
    Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617–31.
    Direct Link:
  • 58
    Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986; 76: 823–31.
  • 59
    Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994; 5: 401–8.
  • 60
    IARC. Weight control and physical activity. In: VanioH, BianchiniF, eds. IARC handbooks of cancer prevention, Vol. 6. Lyon, France: IARC Press, 2002: 120–24.
  • 61
    Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, McLaughlin JK, Nyren O, Adami HO. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999; 42: 107–12.
  • 62
    Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89: 1360–5.
  • 63
    Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194–202.
  • 64
    van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294: 97–104.
  • 65
    Wu T, Willett WC, Hankinson SE, Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005; 28: 1390–6.
  • 66
    Wu LY, Juan CC, Ho LT, Hsu YP, Hwang LS. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 2004; 52: 643–8.
  • 67
    van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477–8.
  • 68
    Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 2004; 291: 1213–9.
  • 69
    Arnaud MJ. Metabolism of caffeine and other components of coffee. In: GarattiniS, ed. Caffeine, coffee and health. New York: Raven Press, 1993. 43–95.
  • 70
    Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst 1993; 85: 1038–49.
  • 71
    Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721–4.
View Full Article (HTML) Get PDF (110K)